Whitepaper: Technology Transfer

By Dr. Holger Gerlach, Head of MSAT Process Transfer DS

In the dynamic world of biopharmaceuticals, Boehringer Ingelheim distinguishes itself through a strong global manufacturing network and a well-established record in technology transfer—a critical process in advancing breakthrough therapies from development to commercialization. Over time, we've refined our transfer methodology to strike the right balance between speed and risk, ensuring efficient and successful outcomes.

With deep scientific expertise and decades of experience, we are a trusted partner for all types of technology transfers, whether in mammalian cell culture or microbial-based biopharmaceuticals. Our comprehensive offering spans the entire value chain—from clinical scale-up to like-for-like transfers of commercial products.

Collaboration and clear communication are central to our approach. Our cross-functional teams work in close partnership with clients to manage the complexities of tech transfers, guided by a six-phase process designed to reduce risk, uphold quality, and accelerate timelines.

This whitepaper explores our systematic strategy for transferring both product and process knowledge, showcasing real-world case studies and expert perspectives. It also emphasizes the critical role of structured project governance and advanced tools — such as Computational Fluid Dynamics — in predicting potential challenges and ensuring smooth, successful transfers.